Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival.

Ferrero, S; Ladetto, M; Drandi, D; Cavallo, F; Genuardi, E; Urbano, M; Caltagirone, S; Grasso, M; Rossini, F; Guglielmelli, T; Cangialosi, C; Liberati, A M; Callea, V; Carovita, T; Crippa, C; De Rosa, L; Pisani, F; Falcone, A P; Pregno, P; Oliva, S; Terragna, C; Musto, P; Passera, R; Boccadoro, M; Palumbo, A

Ferrero, S; Ladetto, M; Drandi, D; Cavallo, F; Genuardi, E; Urbano, M; Caltagirone, S; Grasso, M; Rossini, F; Guglielmelli, T; Cangialosi, C; Liberati, A M; Callea, V; Carovita, T; Crippa, C; De Rosa, L; Pisani, F; Falcone, A P; Pregno, P; Oliva, S; Terragna, C; Musto, P; Passera, R; Boccadoro, M; Palumbo, A.

Affiliation

Ferrero S; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Ladetto M; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Drandi D; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Cavallo F; 1] Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy [2] GIMEMA Italian Myeloma Network, Italy.
Genuardi E; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Urbano M; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Caltagirone S; Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy.
Grasso M; GIMEMA Italian Myeloma Network, Italy.
Rossini F; GIMEMA Italian Myeloma Network, Italy.
Guglielmelli T; GIMEMA Italian Myeloma Network, Italy.
Cangialosi C; GIMEMA Italian Myeloma Network, Italy.
Liberati AM; GIMEMA Italian Myeloma Network, Italy.
Callea V; GIMEMA Italian Myeloma Network, Italy.
Carovita T; GIMEMA Italian Myeloma Network, Italy.
Crippa C; GIMEMA Italian Myeloma Network, Italy.
De Rosa L; GIMEMA Italian Myeloma Network, Italy.
Pisani F; GIMEMA Italian Myeloma Network, Italy.
Falcone AP; GIMEMA Italian Myeloma Network, Italy.
Pregno P; GIMEMA Italian Myeloma Network, Italy.
Oliva S; 1] Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy [2] GIMEMA Italian Myeloma Network, Italy.
Terragna C; GIMEMA Italian Myeloma Network, Italy.
Musto P; GIMEMA Italian Myeloma Network, Italy.
Passera R; Division of Nuclear Medicine, Città della Salute e della Scienza, University of Torino, Torino, Italy.
Boccadoro M; 1] Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy [2] GIMEMA Italian Myeloma Network, Italy.
Palumbo A; 1] Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy [2] GIMEMA Italian Myeloma Network, Italy.

Leukemia ; 29(3): 689-95, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25027515

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Immunoglobulin Heavy Chains / Hematopoietic Stem Cell Transplantation / Multiple Myeloma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2015 Document type: Article Affiliation country: Italia Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google